Dr. Wang has been actively involved in phytopharmaceutical and nutraceutical products research and development in the past 30 years. Currently, he serves as R&D Director at PLC Health Solutions Inc. and also a faculty member of TCM Program at Central College, BC, Canada.
Upon immigrating to Canada, Dr. Wang continued with his research and food/natural health product’s ingredient analysis by spending many years working with U of A research centers and accredited independent labs in Edmonton, Alberta. He was a QA/QC Manager in Labs-Mart Inc. focusing on laboratory operation and quality accreditation from 2013-2015. In 2007-2012, he served as R&D Director and was accountable for regulatory affairs at Pegasus Pharmaceuticals. In 2005-2007, he was a Research Associate at Cross Cancer Institute, University of Alberta and was a Senior Analyst in Division of Food and NHP, ALS Laboratory Group, Edmonton. Previously, Dr. Wang held positions as an Associate Professor in School of Pharmacy, Nanjing University of Traditional Chinese Medicine; and served as Deputy Director of Jiangsu Provincial Centre for Quality Control of Chinese Medicine. Dr. Wang is extensively involved in drug discovery research from screening natural products as drug candidates to translational studies of investigational drugs as well as formulation, pilot-scale development, chromatographic fingerprinting profiles of finished botanicals, and quality control.
Dr. Wang has also been experienced in regulatory affairs with strong knowledge of Canada NHP licensing and US FDA botanical drug IND or dietary supplement as well as China SFDA new drug applications.
Dr. Wang received his Ph.D. in Natural Products Chemistry from Nanjing University of Chinese Medicine in 1997. He then took a postdoctoral position in Institute of Natural Medicine, Toyama Medical and Pharmaceutical University, Japan in 1998 and an industrial postdoctoral fellowship in Jinling Pharmaceutical Company, China in 2000. Dr. Wang has over 50 publications in peer-reviewed journals and 3 china patents of new botanical drugs.
